author-photo

Modupe Idowu

Memorial Hermann Texas Medical Center

1

Papers

0

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Activation of Pyruvate Kinase-R with Etavopivat (FT-4202) Is Well Tolerated, Improves Anemia, and Decreases Intravascular Hemolysis in Patients with Sickle Cell Disease Treated for up to 12 Weeks

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)